|
SNAP29 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.15680000525964E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.03069999979333E-07 |
| Normal-vs-Stage2 |
1.231240E-04 |
| Normal-vs-Stage3 |
1.255540E-03 |
| Normal-vs-Stage4 |
2.19560036818223E-10 |
| Stage1-vs-Stage2 |
7.098000E-01 |
| Stage1-vs-Stage3 |
8.877400E-01 |
| Stage1-vs-Stage4 |
2.638300E-04 |
| Stage2-vs-Stage3 |
7.065200E-01 |
| Stage2-vs-Stage4 |
6.634800E-04 |
| Stage3-vs-Stage4 |
5.085000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.15030000472183E-08 |
| Normal-vs-AfricanAmerican |
1.22220000009499E-07 |
| Normal-vs-Asian |
1.73122000000081E-05 |
| Caucasian-vs-AfricanAmerican |
7.815200E-01 |
| Caucasian-vs-Asian |
2.065200E-01 |
| AfricanAmerican-vs-Asian |
1.280790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.37480005157897E-09 |
| Normal-vs-Female |
5.958100E-03 |
| Male-vs-Female |
2.474400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.12479999998017E-07 |
| Normal-vs-Extreme_Weight |
2.96590000337105E-08 |
| Normal-vs-Obese |
2.863500E-03 |
| Normal-vs-Extreme_Obese |
4.42339999999763E-05 |
| Normal_Weight-vs-Extreme_Weight |
5.314000E-01 |
| Normal_Weight-vs-Obese |
2.568200E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.743800E-01 |
| Extreme_Weight-vs-Obese |
4.010300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.858000E-01 |
| Obese-vs-Extreme_Obese |
1.321620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.368000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.24790000000097E-06 |
| Normal-vs-Age(61-80Yrs) |
1.40329999842592E-08 |
| Normal-vs-Age(81-100Yrs) |
6.7421000005119E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.402800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.562030E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.891700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.576200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.279900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.933600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.64080000042821E-07 |
| Normal-VS-Type2 PRCC |
9.94719999702909E-08 |
| Normal-VS-KIRP CIMP |
3.023600E-02 |
| Normal-VS-Unclassified PRCC |
1.54198999999799E-05 |
| Type1 PRCC-VS-Type2 PRCC |
5.763900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.680200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.118800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.938400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.537000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.984600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.54559999998582E-06 |
| Normal-vs-N1 |
1.158140E-04 |
| Normal-vs-N2 |
6.0524999999978E-05 |
| N0-vs-N1 |
7.505600E-01 |
| N0-vs-N2 |
2.589000E-01 |
| N1-vs-N2 |
3.232000E-01 |
|
|
